Free Trial

Precision BioSciences (DTIL) SEC Filings & 10K Form

Precision BioSciences logo
$4.96 +0.24 (+5.08%)
As of 01/17/2025 04:00 PM Eastern

Recent Precision BioSciences SEC Filings

DateFilerForm TypeView
01/08/2025
7:05 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:00 AM
Germano Geno J (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
6:00 AM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
6:00 AM
Buehler Kevin (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
5:10 AM
Brown Melinda (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:50 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Precision BioSciences (Subject)
Form SC 13G/A
11/14/2024
10:00 AM
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Precision BioSciences (Subject)
Form SC 13G
11/05/2024
6:14 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:14 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:14 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
2:49 PM
Amoroso Michael (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
2:51 PM
Precision BioSciences (Subject)
Scimeca Dario (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
6:15 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
6:15 AM
Precision BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
7:45 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
7:00 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
7:03 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
6:30 AM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
6:30 AM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
6:30 AM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
6:30 AM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
6:30 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
6:30 AM
Precision BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/01/2024
7:00 AM
Precision BioSciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/11/2024
4:12 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:13 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:13 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
2:12 PM
Precision BioSciences (Subject)
SMITH J. JEFFERSON (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
2:15 PM
Precision BioSciences (Subject)
Scimeca Dario (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
7:00 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
3:36 PM
Precision BioSciences (Issuer)
Wadsworth Samuel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:36 PM
Pire Shari Lisa (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:37 PM
Germano Geno J (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:37 PM
Frankel Stanley (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:37 PM
Buehler Kevin (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:37 PM
Brown Melinda (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
6:15 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:15 AM
Precision BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
7:25 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
7:25 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
2025: Crypto Opportunities You Can’t Afford to Miss (Ad)

Cryptocurrencies are once again gaining incredible momentum, and savvy investors are positioning themselves to capitalize on this surge in 2025. The question is—will you be among them? With groundbreaking advancements and increasing institutional adoption on the horizon, there's never been a better time to explore the potential gains in crypto. What’s Fueling the Crypto Comeback?

Get our comprehensive guide, Navigating the Future: Cryptos to Watch in 2025
05/08/2024
7:26 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
7:26 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
7:19 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:26 PM
Precision BioSciences (Issuer)
Wadsworth Samuel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:26 PM
Buehler Kevin (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:26 PM
Pire Shari Lisa (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:25 PM
Brown Melinda (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:25 PM
Frankel Stanley (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:25 PM
Germano Geno J (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:29 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:30 PM
List Alan (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:32 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:33 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:34 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:20 PM
List Alan (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
2:43 PM
Amoroso Michael (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
2:46 PM
Precision BioSciences (Subject)
SMITH J. JEFFERSON (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
2:49 PM
Precision BioSciences (Subject)
Scimeca Dario (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2024
5:34 PM
List Alan (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
2:54 PM
List Alan (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2024
3:32 PM
Precision BioSciences (Filer)
Form DEF 14A
04/25/2024
3:34 PM
Precision BioSciences (Filer)
Form DEFA14A
04/25/2024
3:35 PM
Precision BioSciences (Filer)
Form ARS
04/22/2024
8:12 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
8:12 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
8:12 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
8:12 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:47 PM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
6:15 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
6:15 AM
Precision BioSciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2024
4:28 PM
Aquilo Capital Management, LLC (Filed by)
Precision BioSciences (Subject)
Form SC 13G
03/11/2024
10:21 AM
JANUS HENDERSON GROUP PLC (Filed by)
Precision BioSciences (Subject)
Form SC 13G
03/01/2024
7:00 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
5:00 AM
Precision BioSciences (Subject)
Form FWP
02/29/2024
4:19 PM
Precision BioSciences (Filer)
Form 424B5
02/14/2024
3:37 PM
GREAT POINT PARTNERS LLC (Filed by)
Precision BioSciences (Subject)
Form SC 13G/A
02/13/2024
7:29 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
10:00 AM
Capital World Investors (Filed by)
Precision BioSciences (Subject)
Form SC 13G/A
02/05/2024
3:49 PM
Precision BioSciences (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
01/23/2024
6:11 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
6:13 PM
List Alan (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
6:15 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
6:17 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
6:19 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
4:29 PM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
3:27 PM
Precision BioSciences (Subject)
SMITH J. JEFFERSON (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:42 PM
Precision BioSciences (Subject)
Scimeca Dario (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:42 PM
List Alan (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:46 PM
Amoroso Michael (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DTIL) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners